Skip to main content
PT Organon Pharma Indonesia Tbk logo

PT Organon Pharma Indonesia Tbk — Investor Relations & Filings

Ticker · SCPI ISIN · ID1000088800 IDX Manufacturing
Open in API
Filings indexed 11 across all filing types
Latest filing 2026-05-15 Delisting Announcement
Country ID Indonesia
Listing IDX SCPI

About PT Organon Pharma Indonesia Tbk

https://www.organon.com/indonesia/

PT Organon Pharma Indonesia Tbk is a pharmaceutical company specializing in the manufacturing, packaging, and distribution of a diverse range of pharmaceutical products. Its operations encompass the processing of medicines and health/food supplements for human consumption, including forms such as tablets, capsules, and ointments. The company aligns with a global healthcare mission focused on advancing women's health, supporting their families, and serving the broader communities.

Recent filings

Filing Released Lang Actions
Rencana perubahan status Perseroan dari perusahaan terbuka menjadi perusahaan tertutup atau Rencana Go Private dan penghapusan pencatatan saham Perseroan dari Bursa Efek Indonesia atau Delisting
Delisting Announcement Classification · 85% confidence The document is a formal disclosure by PT Organon Pharma Indonesia Tbk announcing its plan to change status from a public to a private company (“Go Private Plan”) and to delist its shares from the Indonesia Stock Exchange. It primarily describes the material facts of the delisting plan and related shareholder approvals; it is not a full financial report, certification, or AGM materials. This fits the definition of a Delisting Announcement.
2026-05-15 Indonesian
Penyampaian Bukti Iklan Pemberitahuan RUPS
Report Publication Announcement Classification · 80% confidence The document is a formal announcement that PT Organon Pharma Indonesia has published (advertised) its AGM notice in specified media, attaching the advertisement proof. It does not contain the actual notice text, AGM materials, or any substantive financial data; rather it notifies stakeholders and regulators of the publication. Under the “Menu vs Meal” rule, this is a publication announcement rather than the report (or notice) itself, so it falls under Report Publication Announcement (RPA).
2026-05-15 Indonesian
Pemberitahuan Rencana Rapat Umum Pemegang Saham Tahunan dan Luar Biasa
Regulatory Filings Classification · 76% confidence The document is a notice of the planned Annual and Extraordinary General Meeting of Shareholders (AGM/EGM) – it provides meeting date, time, location, and record date. It does not present financial data (so it’s not an annual or interim report), does not include proxy/materials for voting (so not PSI), nor does it report voting outcomes (DVA). It is a general regulatory announcement, so it falls under the fallback category Regulatory Filings (RNS).
2026-05-15 Indonesian
Laporan Bulanan Registrasi Pemegang Efek
Regulatory Filings Classification · 82% confidence The document is a routine monthly securities holder registration report containing detailed shareholding tables, free float calculations, and investor classification for a period ending April 2026. It is not announcing voting results, dividends, financing, management changes, or a corporate action but rather a regulatory periodic report specific to Indonesian market disclosure requirements. There is no threshold crossing or one-off major shareholding change, nor is it just an announcement of a report – it includes full data. This best fits the fallback category for general regulatory filings.
2026-05-08 Indonesian
SCPI - FY 2020 - FS Organon Pharma Indonesia 31 Dec 2020.pdf
Regulatory Filings
2020-12-31 Indonesian
SCPI - FY 2020 - FinancialStatement-2020-Tahunan-SCPI.xlsx
Regulatory Filings
2020-12-31 Indonesian

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.